SCHEMBL30124973

SCHEMBL30124973

COCOc1cc(-c2ccc3c(N4CCCOCC4=O)nc(Cl)nc3c2C)c2ccccc2c1

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 10/20 0.34
TUBB4A P04350 2/20 0.33
TUBB P07437 2/20 0.33
TUBA3C P0DPH7 2/20 0.33
TUBA1B P68363 2/20 0.33
TUBA4A P68366 2/20 0.33
TUBB4B P68371 2/20 0.33
TUBB3 Q13509 2/20 0.33
TUBB2A Q13885 2/20 0.33
TUBB8 Q3ZCM7 2/20 0.33
TUBA3E Q6PEY2 2/20 0.33
TUBA1A Q71U36 2/20 0.33
TUBA1C Q9BQE3 2/20 0.33
TUBB6 Q9BUF5 2/20 0.33
TUBB2B Q9BVA1 2/20 0.33
TUBB1 Q9H4B7 2/20 0.33
EGFR P00533 1/20 0.33
PDGFRB P09619 1/20 0.33
KDR P35968 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24712891 1.00 PTGS2 (0.34) PTGS2TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL24712653 0.89 TUBB4A (0.33) PTGS2TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL30125111 0.89 TUBB4A (0.33) PTGS2TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL24712894 0.84 KRAS (0.40)
SCHEMBL30125130 0.79 KRAS (0.42)
SCHEMBL29140570 0.79 KRAS (0.42)
SCHEMBL24712662 0.75 KRAS (0.38)
SCHEMBL24712889 0.74 PTGS2 (0.39) PTGS2
SCHEMBL27191232 0.74 KRAS (0.52)
SCHEMBL24711962 0.72 KRAS (0.49)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4352061-A1 QUINAZOLINE DERIVATIVES USEFUL AS RAS INHIBITIORS Redx Pharma Plc (GB) 2024-04-17 EP disclosed
CN-117425658-A Quinazoline derivatives as RAS inhibitors 莱德克斯制药公共有限公司 2024-01-19 CN disclosed
WO-2022258974-A1 QUINAZOLINE DERIVATIVES USEFUL AS RAS INHIBITIORS REDX PHARMA PLC (GB) 2022-12-15 WO disclosed